Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 1/20 | 0.37 |
| ▸ | CD81 | P60033 | 2/20 | 0.36 |
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809454 | 0.83 | TBXAS1 (0.37) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL809452 | 0.83 | TBXAS1 (0.37) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL1317422 | 0.82 | EP300 (0.48) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL1317424 | 0.82 | EP300 (0.48) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL11211538 | 0.82 | EP300 (0.43) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL18920825 | 0.82 | TBXAS1 (0.36) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL18920824 | 0.82 | TBXAS1 (0.36) | TBXAS1CD81EP300PPARGBACE1 | |
| SCHEMBL21220131 | 0.80 | TBXAS1 (0.35) | TBXAS1CD81EP300PPARG | |
| SCHEMBL20637512 | 0.80 | TBXAS1 (0.35) | TBXAS1CD81EP300PPARG | |
| SCHEMBL20637513 | 0.80 | TBXAS1 (0.35) | TBXAS1CD81EP300PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279252-A1 | AQUEOUS COMPOSITION AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-08-22 | — | — | US | disclosed |
| EP-4361161-A1 | AQUEOUS COMPOSITION AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-11670740-B2 | Conversion layer, light emitting device and method of producing a conversion layer | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| WO-2021058464-A1 | CONVERSION LAYER, LIGHT EMITTING DEVICE AND METHOD OF PRODUCING A CONVERSION LAYER | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2021-04-01 | — | — | WO | disclosed |
| US-20210098655-A1 | Conversion Layer, Light Emitting Device and Method of Producing a Conversion Layer | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2021-04-01 | — | — | US | disclosed |
| US-8557350-B2 | Method for bonding a layer of silicone to a substrate of methacrylate polymer | SILICON BIOSYSTEMS S.P.A. (IT) | 2013-10-15 | — | — | US | disclosed |
| US-20110193006-A1 | Method for Bonding a Layer of Silicone to a Substrate of Methacrylate Polymer | SILICON BIOSYSTEMS S.P.A. | 2011-08-11 | — | — | US | disclosed |
| WO-2009022222-A2 | METHOD FOR BONDING A LAYER OF SILICONE TO A SUBSTRATE OF METHACRYLIC POLYMER | SILICON BIOSYSTEMS S.P.A. (IT) | 2009-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279252-A1 | AQUEOUS COMPOSITION AND METHOD FOR PRODUCING SAME | ADH1C, ADH1A, AQP1 | TBXAS1 1297/4885CD81 2252/4885EP300 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.